World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
141
Citations
75460
World Ranking
1622
National Ranking
944

Research.com Recognitions

  • 2005 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Paul A. Bunn is affiliated with the University of Colorado Boulder in the United States and specializes in the field of Medicine with a focus on oncology and pulmonary research.

Their research contributions primarily cover the following main topics:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • COVID-19 and healthcare impacts
  • Neuroendocrine Tumor Research Advances

Their work spans multiple subfields including:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Epidemiology

Frequent co-authors in their publications include:

  • Fred R. Hirsch
  • Ignacio I. Wistuba
  • Mark G. Kris
  • Philip C. Mack
  • David P. Carbone

They have published extensively in several prominent venues with the majority of their work appearing in:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Clinical Lung Cancer
  • Nature Medicine
  • Annals of Oncology

Among their recent papers are:

  • "IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy," 2020, Journal of Thoracic Oncology
  • "Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions," 2023, CA A Cancer Journal for Clinicians
  • "Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial," 2022, Nature Medicine
  • "Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy," 2023, Journal of Clinical Oncology
  • "Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution," 2020, Molecular Oncology

Paul A. Bunn has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2005.

Best Publications

  • Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

    Bernard J. Poiesz;Francis W. Ruscetti;Adi F. Gazdar;Paul A. Bunn

  • Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

    Nasser Hanna;Frances A. Shepherd;Frank V. Fossella;Jose R. Pereira

  • Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

    Federico Cappuzzo;Fred R. Hirsch;Elisa Rossi;Stefania Bartolini

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Michael V. Di Maria

  • Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

    Karen Kelly;John Crowley;Paul A. Bunn;Cary A. Presant

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

    T. Lindmo;E. Boven;F. Cuttitta;J. Fedorko

  • Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Wilbur A. Franklin

  • Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

    Fred R. Hirsch;Marileila Varella-Garcia;Jason McCoy;Howard West

  • Small-cell lung cancer: what we know, what we need to know and the path forward

    Adi F. Gazdar;Paul A. Bunn;John D. Minna

  • Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

    Nasser Hanna;Paul A. Bunn;Corey Langer;Lawrence Einhorn

  • Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology

    Fred R. Hirsch;Wilbur A. Franklin;Adi F. Gazdar;Paul A. Bunn

  • Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    Andrew J. Weickhardt;Benjamin Scheier;Joseph Malachy Burke;Gregory Gan

  • Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

    Bunn Pa;Lamberg Si

  • Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

    J. Whang-Peng;C. S. Kao-Shan;E. C. Lee;P. A. Bunn

  • CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.

    John L. Nugent;Paul A. Bunn;Mary J. Matthews;Daniel C. Ihde

  • Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

    Adi F. Gazdar;Desmond N. Carney;Desmond N. Carney;Paul A. Bunn;Paul A. Bunn;Edward K. Russell;Edward K. Russell

  • New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.

    Paul A. Bunn;Karen Kelly

  • Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

    Samir E. Witta;Robert M. Gemmill;Fred R. Hirsch;Christopher D. Coldren

Frequent Co-Authors

Wilbur A. Franklin
Wilbur A. Franklin University of Colorado Denver
John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Fred R. Hirsch
Fred R. Hirsch Mount Sinai Hospital
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Robert C. Doebele
Robert C. Doebele University of Colorado Denver
Bruce E. Johnson
Bruce E. Johnson Harvard University
D. Ross Camidge
D. Ross Camidge University of Colorado Anschutz Medical Campus
David J. Kwiatkowski
David J. Kwiatkowski Brigham and Women's Hospital
Anna E. Barón
Anna E. Barón University of Colorado Anschutz Medical Campus
Daniel C. Ihde
Daniel C. Ihde National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can help you fast-track your career in healthcare and medicine. For nursing professionals seeking advanced roles, affordable dnp programs provide a cost-effective way to earn a Doctor of Nursing Practice degree and move into leadership or specialized clinical positions.

Entry-level nursing remains a popular and rewarding pathway. If you’re looking to start quickly, lpn programs offer accelerated training to become a Licensed Practical Nurse, combining flexibility with the practical skills needed in many healthcare settings.

There is also growing demand for mental health practitioners. By enrolling in online psych np programs, you can specialize in psychiatric mental health and help address the increasing need for mental health services in the USA.

Those interested in the administrative side of healthcare will find options like healthcare administration degrees. These programs teach essential leadership skills and open doors to a variety of non-clinical roles in hospitals, clinics, and health systems.

Best Scientists Citing Paul A. Bunn

Trending Scientists

Recently Published Articles